Back to 
Woodline Partners LP
Woodline Partners LP
SGEN
Showing 0 of 5 quarters
Position history for Woodline Partners LP's holdings in SEATTLE GENETICS INC
As of its Q3 2020 13F, Woodline Partners held 317,487 shares of SGEN (Seattle Genetics), worth $62.1M. Woodline Partners' 13F filings listed SGEN from Q4 2019 to Q3 2020, 4 quarterly filings. SGEN was 2.0% of Woodline Partners' reported 13F portfolio.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.